Development and evaluation of a patient-reported outcome measure specific for Gaucher disease with or without neurological symptoms in Japan

被引:1
作者
Narita, Aya [1 ]
Koto, Yuta [2 ]
Noto, Shinichi [3 ]
Okada, Masafumi [4 ]
Ono, Midori [5 ]
Baba, Terumi [5 ]
Sagara, Rieko [5 ]
Sakai, Norio [6 ]
机构
[1] Tottori Univ, Div Child Neurol, Inst Neurol Sci, Fac Med, Yonago, Japan
[2] Osaka Aoyama Univ, Fac Hlth Sci, Sch Nursing, Osaka, Japan
[3] Niigata Univ Hlth & Welf, Dept Rehabil, Niigata, Japan
[4] IQVIA Solut Japan KK, Real World Evidence Solut & HEOR, Tokyo, Japan
[5] Takeda Pharmaceut Co Ltd, Japan Med Off, Tokyo, Japan
[6] Osaka Univ, Grad Sch Med, Div Hlth Sci, Child Healthcare & Genet Sci Lab, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan
关键词
Gaucher disease; Japan; Patient reported outcome measures; Quality of life; Burden of disease; Neuronopathic Gaucher disease; Reliability; Validity;
D O I
10.1186/s13023-023-02996-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Patients with Gaucher disease (GD), a rare lysosomal storage disorder, have reduced health-related quality of life (HRQOL). A patient-reported outcome measure (PROM) for HRQOL developed for type 1 GD (GD1) is not appropriate for patients with neuronopathic GD (nGD) types 2 (GD2) and 3 (GD3). In this study, we developed a new PROM for use in all GD types. We previously reported the qualitative analysis of interviews with Japanese patients with nGD, which was used to create nGD-specific PROM items. Here we evaluated the full PROM combining the type 1 questionnaire with the new nGD-specific items.Methods Patients with confirmed GD were recruited (Association of Gaucher Disease Patients in Japan or leading doctors) for pre-testing (May 2021) or the main survey (October-December 2021). The PROM had three parts: Parts 1 and 2 were translated into Japanese from the pre-existing GD1 PROM, whereas Part 3 was newly developed. Patients (or their caregivers, where necessary) completed the PROM questionnaire on paper and returned it by mail. Mean scores were determined overall and by GD type. Inter-item correlations, content consistency (Cronbach's alpha), and test-retest reliability (Cohen's kappa; main survey only, taken 2 weeks apart) were calculated.Results Sixteen patients (three with GD1; six with GD2; seven with GD3) and 33 patients (nine with GD1; 13 with GD2; 11 with GD3) participated in the pre-test and main survey, respectively. All GD2 patients and one-third (6/18) of GD3 patients required caregivers to complete the questionnaire. Mean scores indicated that the burden was highest in GD2 and lowest in GD1. In the main survey, internal consistency was high (Cronbach's alpha = 0.898 overall, 0.916 for Part 3), and test-retest reliability was high for Part 3 (kappa > 0.60 for 13/16 items) but low for Part 1 (kappa < 0.60 for 12/15 items).Conclusions We have developed a flexible and reliable PROM that can be tailored for use in all types of GD and propose using Parts 1 and 2 for GD1, Parts 2 and 3 for GD2, and Parts 1, 2, and 3 for GD3.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Development of a patient-reported outcome measure for the foot affected by rheumatoid arthritis
    Walmsley, Steven
    Ravey, Mike
    Graham, Andrea
    Teh, Lee S.
    Williams, Anita E.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2012, 65 (04) : 413 - 422
  • [42] Patient-reported outcome measures in cardiovascular disease
    Kornowski, Ran
    [J]. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2023, 9 (02) : 119 - 127
  • [43] Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO
    Goswami, Pushpendra
    Oliva, Esther N.
    Ionova, Tatyana
    Else, Roger
    Kell, Jonathan
    Fielding, Adele K.
    Jennings, Daniel M.
    Karakantza, Marina
    Al-Ismail, Saad
    Collins, Graham P.
    McConnell, Stewart
    Langton, Catherine
    Al-Obaidi, Magda J.
    Oblak, Metod
    Salek, Sam
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [44] Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research
    Otten, Marina
    Augustin, Matthias
    Blome, Christine
    Topp, Janine
    Niklaus, Marina
    Hilbring, Caroline
    Bechara, Falk G.
    Pinter, Andreas
    Zouboulis, Christos C.
    Anzengruber, Florian
    Kirsten, Natalia
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103
  • [45] Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines
    Navarra, S. V.
    Tanangunan, R. M. D. V.
    Mikolaitis-Preuss, R. A.
    Kosinski, M.
    Block, J. A.
    Jolly, M.
    [J]. LUPUS, 2013, 22 (03) : 262 - 267
  • [46] Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease
    Neijenhuis, Myrte K.
    Gevers, Tom J. G.
    Hogan, Marie C.
    Kamath, Patrick S.
    Wijnands, Titus F. M.
    van den Ouweland, Ralf C. P. M.
    Edwards, Marie E.
    Sloan, Jeff A.
    Kievit, Wietske
    Drenth, Joost P. H.
    [J]. HEPATOLOGY, 2016, 64 (01) : 151 - 160
  • [47] The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas
    Heaney, Alice
    Wilburn, Jeanette
    Rouse, Matthew
    Langmead, Shannon
    Blakeley, Jaishri O.
    Huson, Susan
    McKenna, Stephen P.
    [J]. MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (12):
  • [48] Development and validation of a new patient-reported outcome measure for patients with pressure ulcers: the PU-QOL instrument
    Gorecki, Claudia
    Brown, Julia M.
    Cano, Stefan
    Lamping, Donna L.
    Briggs, Michelle
    Coleman, Susanne
    Dealey, Carol
    McGinnis, Elizabeth
    Nelson, Andrea E.
    Stubbs, Nikki
    Wilson, Lyn
    Nixon, Jane
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
  • [49] Evaluation of shoulder-specific patient-reported outcome measures: a systematic and standardized comparison of available evidence
    Schmidt, Stefanie
    Ferrer, Montse
    Gonzalez, Marta
    Gonzalez, Nerea
    Maria Valderas, Jose
    Alonso, Jordi
    Escobar, Antonio
    Vrotsou, Kalliopi
    [J]. JOURNAL OF SHOULDER AND ELBOW SURGERY, 2014, 23 (03) : 434 - 444
  • [50] Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
    Becker, Mike O.
    Dobrota, Rucsandra
    Garaiman, Alexandru
    Debelak, Rudolf
    Fligelstone, Kim
    Kennedy, Ann Tyrrell
    Roennow, Annelise
    Allanore, Yannick
    Carreira, Patricia E.
    Czirjak, Laszlo
    Denton, Christopher P.
    Hesselstrand, Roger
    Sandqvist, Gunnel
    Kowal-Bielecka, Otylia
    Bruni, Cosimo
    Matucci-Cerinic, Marco
    Mihai, Carina
    Gheorghiu, Ana Maria
    Mueller-Ladner, Ulf
    Sexton, Joseph
    Kvien, Tore K.
    Heiberg, Turid
    Distler, Oliver
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (04) : 507 - 515